Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mitochondrial uncoupling protein 1 (UCP1) gene promoter is a critical regulatory region of the nuclear genome that controls the expression of UCP1, also known as thermogenin [UniProt P25874]. This genomic locus is primarily active in brown and beige adipose tissue, where it facilitates non-shivering thermogenesis by allowing protons to leak across the inner mitochondrial membrane, bypassing ATP synthase and dissipating energy as heat [PubMed: 24122173]. The promoter contains complex regulatory elements, including response elements for peroxisome proliferator-activated receptor gamma (PPAR-gamma), thyroid hormone receptors, and retinoic acid receptors, which serve as docking sites for transcription factors that drive gene expression [PubMed: 10617604]. Targeting this locus is a significant area of research for treating obesity and type 2 diabetes, as increasing UCP1 expression can enhance systemic energy expenditure and improve insulin sensitivity [PubMed: 32024743]. Drugs like mirabegron and thiazolidinediones indirectly target this region by activating signaling pathways or transcription factors that bind to the promoter to induce 'browning' of white fat [PubMed: 8621422]. Therapeutic challenges include ensuring tissue-specific activation to avoid systemic hyperthermia or cardiovascular side effects associated with broad metabolic stimulation.
Transcriptional upregulation of UCP1 expression to induce mitochondrial proton leak and dissipate energy as heat in adipose tissue.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial uncoupling protein 1 gene promoter (UCP1 promoter).